{
    "nctId": "NCT03039127",
    "briefTitle": "Immunostimulating Interstitial Laser Thermotherapy in Breast Cancer",
    "officialTitle": "Interstitial Laser Thermotherapy (imILT) as a Treatment Option in Breast Cancer Patients Not Suitable for Surgical Excision",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 3,
    "primaryOutcomeMeasure": "Treatment effect by radiology",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Have histologically confirmed breast cancer\n2. Hormone receptor positive or negative\n3. Have assessable tumour by MRI or ultrasound\n4. Are patients deemed unfit for surgical excision of tumour under general anaesthetic.\n5. Have been given informed verbal and written consent for participation in the trial\n6. Have stable hematologic, renal and hepatic functions.\n\nExclusion Criteria:\n\n1. Are known to be HIV positive\n2. Have active autoimmune disease\n3. Are on corticosteroid medication\n4. Have evidence of bleeding diathesis or coagulopathy.",
    "sex": "ALL",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}